Following up on the Q&A session during our webinar, we collected questions passed on by attendees and would like to share them with as well.

1. When submitting the filing to the regulator we often get feedback about errors in submission, but without detailed explanation on where these errors are located. Is there any way to be 100% sure, that submitted report is correct?

   What we know from experience, that except of supporting a given regulatory frameworks e.g. EBA CRD IV / CRR the reporting tool should run data validation checks against both XBRL and non-XBRL rules (when taxonomy issuer (EBA/EIOPA) introduces new version of taxonomy not all validation rules are reflected in the published list of business validations). Apart from that it is appreciated when the tool has a comprehensive validation errors display panel in which you could find all the necessary information – tables and cells affected by the error, exact validation code from the taxonomy and mathematical logic of the error. Lastly, most errors are human errors, so the regulatory reporting software should be as intuitive and user-friendly as possible.

2. If I understood well, your expectation is that EBA will publish DPM v2.10 phase 2 (including the new Covid-19 measures reports) on 10th July, can you confirm it? When we can expect that BR-AG implements it in ATOME: Particles?

   That is correct, we expect that DPM v2.10 phase 2 will contain Covid-19 measures reports, at the moment we assume that EBA will publish the package on 10th of July, but slight delays are possible. Regarding the implementation in ATOME: Particles, it will take probably a week from the moment of publication by the EBA.